Chronic Kidney Disease

Researchers Discuss Closing Racial Gaps in ESKD Incidence Rates

December 19th 2020, 6:30am

Video

Bringing together genetic work with social determinants of health can improve understanding of factors associated with ESKD disparities, said Adriana Hung, MD, MPH, associate professor of medicine at Vanderbilt University, and Bryce Rowan, a statistical genetic analyst.

Study Describes Early Benefit, Effectiveness of RASi for CKD

December 18th 2020, 5:45pm

Article

An observational study showed that it may be more effective to start patients on a renin-angiotensin system inhibitor (RASi) than a calcium channel blocker in delaying progression of advanced kidney disease.

Study Shows Effect of COVID-19 on Hospitalization Risk in CKD

December 12th 2020, 9:45pm

Article

Patients with COVID-19 and end-stage renal disease were 11 times more likely to be admitted to the hospital than patients without kidney disease.

Dr George Bakris on Discontinuation Rates, CV Outcomes of FIDELIO-DKD

December 12th 2020, 4:45pm

Video

A variety of factors contributed to discontinuation rates in FIDELIO-DKD, said George Bakris, MD, professor of medicine and director of the American Heart Association Comprehensive Hypertension Center at the University of Chicago Medicine.

Study Examines Clinical Implications of Removing Race From eGFR in CKD

December 4th 2020, 3:51pm

Article

As higher estimated glomerular filtration rate (eGFR) equations indicate better kidney function, there has been increasing recognition that this may lead to inequitable and delayed care in treating chronic kidney disease (CKD) in Black adults.

Dr Jill Krissberg on Addressing Racial Disparities in Glomerular Disease

December 3rd 2020, 6:00pm

Video

Making sure patients have a strong medical home and close follow-up is one way to reduce glomerular disease disparities among children, said Jill Krissberg, MD, a pediatric nephrology fellow at Stanford University School of Medicine.

Contributor: The Wrong Way to Design a Medicare Mandatory Demonstration

November 27th 2020, 1:00pm

Article

Jackson Williams is vice president, public policy at Dialysis Patient Citizens. Previously he worked at the Centers for Medicare and Medicaid Services (CMS); was a health services researcher in the AARP Public Policy Institute; and a lobbyist on health policy issues for 3 nonprofit associations. His more than 2 decades of experience monitoring, studying, and overseeing federal demonstration projects include time as a project officer at CMMI and serving as the consumer representative on a Medicare pilot site’s governing body.

Dr George Bakris Discusses Next Steps for Finerenone

November 27th 2020, 12:15pm

Video

If results from FIGARO-DKD are as positive as those of FIDELIO-DKD, the field will work aggressively to get the message out, said George Bakris, MD, professor of medicine and director of the American Heart Association Comprehensive Hypertension Center at the University of Chicago Medicine.

Dr George Bakris Speaks About Increasing Minority Representation in CKD Trials

November 21st 2020, 3:45pm

Video

In the FIDELIO-DKD trial researchers purposely recruited centers that had very large African American databases, said George Bakris, MD, professor of medicine and director of the American Heart Association Comprehensive Hypertension Center at the University of Chicago Medicine.

Even in Advanced CKD, Canaglifozin Slows Rate of Kidney Decline, Study Says

November 19th 2020, 10:00pm

Article

A new analysis of CREDENCE data showed that the sodium-glucose cotransporter 2 (SGLT2) inhibitor worked in advanced disease and without causing acute kidney injury.